The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a "quad-demic." Here what you can do.

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's ...

There are hygiene tips to reduce the likelihood of getting sick. Public health officials are warning that the U.S. could be ...

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.

Human metapneumovirus (hMPV) cases continue to be reported in several states across India, although the number of cases is ...

Kentucky is seeing a “very high” rate of respiratory illness, especially among children. “We are seeing somewhere between 10 ...

An extended flu vaccine rollout would benefit public health and the economy, writes Lindsay Broadbent Every year, as the weather turns colder, we can’t go far without hearing someone cough or sniffle.

However, compared to influenza and RSV, or respiratory syncytial virus, cases of COVID-19 are considered “low” by the CDC. Flu cases were labeled as “high,” and RSV cases were categorized ...